Friday, 20 May 2022
  
Login

Australia's most trusted
source of pharma news

Friday, 20 May 2022
Ascott 3
Ascott 3
Rising star redefines success

In six months, Joy Boulos has won Medical Affairs Professional of the Year and jumped up the career ladder to a new company and new role - but this leader thinks outside the box when it comes to success.

Last minute election face off
MA wins promises from both parties on the eve of polling day
TODAY
Botox saga stretches on
Legal action over 'alternative Botox' products moves to the High Court
TODAY
Aussie's US cancer milestone
Sydney company puts novel cancer-killing virus therapy to the test
TODAY
Medical Director
Medical Director
'Soft' perks the new job bait
Employee benefits shifting to less tangible rewards
19 May
Novartis patient program awarded
Global recognition for boosting medicines adherence
19 May
Name change for GlaxoSmithKline
Ahead of spin off, company changes the name it's had for 22 years
18 May
Great place to work... already?
One pharma proves it doesn't take much time to be a great workplace
18 May
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (12)

Sales & Customer Relations (34)

Access & Reimbursement (5)

Clinical & Medical, R&D (13)

Regulatory, Pharmacovigilance & QA (6)

Devices (2)

Other (32)

Nice work: 200% growth Q1
But how long can it last with investor interest declining
19 May
Janssen ups pressure on PBAC
Consumers with major depression urged to submit their stories
19 May
Novo battles off-label Ozempic
Diabetes patients must come before weight loss candidates
19 May
Fines pile up in TGA mini-blitz
Nine fines totalling more than $100,000 for multiple breaches
19 May
Roche puts the brakes on travel
Committing to reduced travel as part of an ambitious environmental plan
18 May
Pfizer reveals service scorecard
Company's social responsibility extends well beyond providing medicines
18 May
Janssen shakes up reimbursement
Candid report highlights the need for earlier government funding
18 May
Off-label drug win for patients
Halves risk of losing kidney function and kidney failure, study shows
18 May
WFH starting to show cracks
Gloss comes off work from home as staff struggle to disconnect
17 May
$700K for one day? Not so fast
Moderna could clawback the handsome payout to its former CFO
17 May
Aussie jabs go head-to-head
First volunteers already dosed with next-gen homegrown vaccines
17 May
Pfizer gears up for migraine battle
Will the road to reimbursement be as tough as it was for rival drugs?
17 May
Pitch for billion dollar industry
Election statement names priorities for genomics and precision health
17 May
Firms on the leadership hunt
Local offices advertising for top talent to fill senior roles
17 May
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.